
|Articles|November 7, 2022
BGB Group Appoints Fred Bennett As Chief Digital Officer
Advertisement
BGB group, a healthcare advertising, medical education, and strategic consulting agency, announced that Fred Bennett has been named as the firm’s first-ever Chief Digital Officer (CDO).
In his role, Fred will focus on leading and managing the digital teams within BGB Group and strengthening the agency’s long-term plan for leveraging new technologies, innovation, and customer insights to meet client needs in the healthcare industry. Reporting to the agency’s Managing Partners, the CDO will be a key member of the BGB Group executive team.
Continue reading
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5




